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Are current guidelines for sun protection optimal
for health? Exploring the evidence†
Robyn M. Lucas, *a Rachel E. Neale, b Sasha Madronich c and
Richard L. McKenzie d
Exposure of the skin to ultraviolet (UV) radiation is the main risk factor for skin cancer, and a major source
of vitamin D, in many regions of the world. Sun protection messages to minimize skin cancer risks but
avoid vitamin D deficiency are challenging, partly because levels of UV radiation vary by location, season,
time of day, and atmospheric conditions. The UV Index provides information on levels of UV radiation and
is a cornerstone of sun protection guidelines. Current guidelines from the World Health Organization are
that sun protection is required only when the UV Index is 3 or greater. This advice is pragmatic rather than
evidence based. The UV Index is a continuous scale; more comprehensive sun protection is required as
the UV Index increases. In addition, a wide range of UVA doses is possible with a UVI of 3, from which
there may be health consequences, while full sun protection when the UVI is “moderate” (between 3 and
5) may limit vitamin D production. Finally, the duration of time spent in the sun is an essential component
of a public health message, in addition to the intensity of ambient UV radiation as measured by the UV
Index. Together these provide the dose of UV radiation that is relevant to both skin cancer genesis and
vitamin D production. Further education is required to increase the understanding of the UV Index; mess-
ages framed using the UV Index need to incorporate the importance of duration of exposure and increas-
ing sun protection with increasing dose of UV radiation.
Introduction
Sun exposure has both harms and benefits. It is the primary
risk factor for skin cancer but a major source of vitamin D, in
many regions of the world. Providing accurate, evidence-based
public health messages about optimal sun exposure is challen-
ging, because ambient ultraviolet (UV) radiation varies accord-
ing to location, time of day, time of year, and in relation to the
weather (e.g. clouds) and other atmospheric conditions, and
populations vary with respect to skin types and habitual sun
exposure behaviours. Nevertheless, such messages are impor-
tant globally. In the modern world all skin types are present at
all latitudes, and levels of UV radiation exceed the threshold
above which WHO guidelines advise sun protection1 in all
countries in their summer, and every day of the year for over
half of the globe. Peak levels of UV radiation are considered
“extreme” for over half of the globe during summer.2
Solar UV radiation at Earth’s surface is predominantly
within the UVA waveband (315–400 nm). UVB wavelengths
(280–315 nm) are largely filtered out by stratospheric ozone
and make up less than 5% of UV radiation at Earth’s surface.3
The intensity of ambient UV radiation decreases with increas-
ing distance from the Equator, is higher in summer than
winter, and varies across the day with peak levels at solar
noon. This variability relates to the solar zenith angle (SZA)
which is the angular distance that the sun is away from being
directly overhead. The larger the SZA, the lower the sun is in
the sky and the longer the distance through the atmosphere,
with more attenuation, particularly of UVB. These factors,
along with variability in ozone, alter both the intensity and the
spectral composition of UV radiation at Earth’s surface, as
illustrated in Table 1. This complexity has made it difficult to
provide simple messages about how much time people should
spend outdoors and when sun protection is needed.
The relative biological effectiveness of different wavebands
of UV radiation is described by the action spectrum for a
specific outcome such as development of erythema (sunburn)
or production of vitamin D.4 The action spectra for these two
outcomes are different (see Fig. S1†). While UVB wavelengths
are most effective for both, UVA wavelengths have some effec-
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tiveness for erythema but virtually none for vitamin D pro-
duction. Action spectra for other outcomes, such as skin
cancers, are defined in animal models but not in humans5
and the erythemal action spectrum is most commonly used in
relation to adverse effects of UV radiation on human health.
In recent years, the UV Index (UVI), a measure of the erythe-
mal UV radiation at Earth’s surface,6 has been used to guide
sun protection messages, although public knowledge and
understanding of the UVI remains generally poor.7 UVI values
are continuous but typically rounded to an integer value and
are directly measured in situ or predicted from atmospheric
parameters. The UVI is available in weather forecasts, online
and through smartphone apps. Messages framed using the
UVI obviate the need for specific sun protection messages
according to time of day, time of year, and location, as these
are already incorporated into the UVI value. Measured UVI also
takes account of cloud conditions.
The World Health Organization, through its INTERSUN
program, has provided some international consistency in sun
protection messaging using the UVI.1 INTERSUN advises that
sun protection should be used when the UVI (measured or pre-
dicted) is 3 or higher.1 The implicit corollary is that it is safe to
be in the sun without protection when the UVI is less than 38
and the guidelines note that at UVI levels of 1 and 2 you can
safely stay outside. There is, however, little evidence to support
a specific UVI cut-point. In some countries, e.g. Australia, New
Zealand and USA, a “UV Sun Protection Alert Period” is issued
for the entire period of the day when the forecast clear-sky UVI
is 3 or greater (Australia and New Zealand)9 or 6 or greater
(USA).10 In some regions in summer, this covers most of the day.
Here we evaluate several issues concerning the use of the
UVI to underpin messages about sun protection, integrating
published health data with those from atmospheric monitoring
of UV radiation. We begin with a brief review of the biological
effects of exposure to UV radiation, and the relevant wavebands.
Biological effects of UVB and UVA
Exposure to UV radiation is the primary cause of sunburn,
photoageing of the skin, a range of benign lesions such as
actinic keratoses, and skin cancers. There appears to be no
threshold dose of UV radiation for the induction of skin
cancer and thus no safe limit of exposure.11 High-intensity sun
exposure also causes photokeratitis and photoconjunctivitis of
the eyes, and chronic exposure leads to cataract and pterygium.
Both local and systemic immune suppression follow sun
exposure and contribute to skin cancer development and the
reactivation of latent viral infections (reviewed in ref. 12).
The most well-established beneficial effect of skin exposure
to UV radiation is production of vitamin D. A number of other
potentially beneficial products are formed in the skin follow-
ing UV irradiation, such as nitric oxide13 and prostaglandin
E2,14 but research on these factors is less advanced (reviewed
in ref. 12).
Mechanistic studies implicate UVB as the main causative
waveband for both skin cancer induction and vitamin D pro-
duction but there is increasing evidence that the UVA wave-
band is also important. UVA exposure has been implicated in
the development of melanoma and possibly basal cell carci-
noma,15,16 as well as in the production of nitric oxide that may
have benefits for cardiovascular health.17 Both UVA and UVB
irradiation cause immune suppression, acting through a range
of different chromophores with specific absorption spectra.18,19
Recent research suggests that UV-induced immune suppression
could have both benefits (e.g., suppressing autoimmunity20) and
adverse effects (e.g., suppressing immune responses to vacci-
nation21) for human health. Although UVB photons are more
effectively immunosuppressant, UV-induced immune suppres-
sion may be mainly UVA-induced since there is a peak of immune
suppression in the UVA waveband and UVA is much more abun-
dant at Earth’s surface than UVB (see Table 1 and Fig. S1†).18
Using the UVI to guide time outdoors
and sun protection recommendations
The UVI is a unitless number, defined as 40 times the erythe-
mally weighted UV irradiance, UVEry, expressed in Watts per
metre2 (W m−2).
UVI ; 40 UVEry ðW m2Þ ðthe definition of UVIÞ
Table 1 UVI and approximate contributions (W m−2) to solar energy from UVA and UVB (at the mean distance from Earth to the Sun, i.e. 1 AU,
cloudless skies, no aerosols, solar constant = 1370 W m2) (adapted from ref. 3). At solar zenith angles (SZAs) of 0° and 60°, the depth of the ozone
layer (in Dobson units, DU) causes strong variation in UVI and UVB, with little change in UVA
Conditions SZA (°) Total ozone (DU) UVI UVB (W m−2) (280–315 nm) UVA (W m−2) (315–400 nm)
Extra-terrestrial (altitude 70 km) 0 0 ∼280a 14.7 85.4
Earth’s surface (altitude 0 km) 0 100 42.3 4.51 66.1
300 12.1 2.19 65.2
450 7.4 1.47 64.6
60 100 7.9 1.19 27.3
300 2.1 0.42 26.7
450 1.4 0.23 26.0
a Exact value depends on the lower wavelength limit of the integration. Here the lower limit is taken as 280 nm. See Fig. S1 for detailed spectral
variations of the irradiances.
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Since the UVI is a measure of erythemal UV radiation, mess-
ages based on the UVI primarily focus on avoiding sunburn.
UVI and UVEry are measures of the intensity of UV radiation at
any given moment. However, health effects occur in relation to
the total dose of UV radiation, which includes both the inten-
sity and the duration of exposure. The time-averaged erythemal
dose (e.g., over 5–10 minutes) is typically provided in units of
Joules per m2 (J m−2) or standard erythemal doses (SEDs),
where 1 SED = 100 J m−2 of erythemal UV radiation. There is a
simple mathematical relationship between the UVI and the
number of SEDs as shown below:
The dose received in 1 hour is:
Hourly erythemal doseðJm2Þ ¼UVEry  3600 s per hour
¼ð3600=40Þ  UVI
¼ 90 UVIðJm2Þ
¼ 0:9 UVIðSEDÞ
Thus, if UVI = 10, the hourly erythemal dose = 900 J m−2
which is equivalent to 9 SEDs; thus an individual in full sun-
light will receive 9 SEDs per hour. A conservative approxi-
mation is that the dose of sunburning UV radiation (in SEDs)
received in one hour is estimated by the average UVI for that
hour. For example, if the average UVI is 6, the number of SEDs
received in one hour is ∼6 (actually 5.4, with the approxi-
mation providing a small safety factor); thus, 60/UVI approxi-
mates the number of minutes to receive 1 SED (on a horizontal
unshaded surface).
Individual sensitivity to UV radiation varies, both for
erythema and vitamin D production, according to skin type,
genetics, age and prior sun exposure (leading to tanning and
epidermal hyperplasia).22 For erythema, this is described by
the minimal erythema dose (MED) – the dose of erythemally
weighted UV radiation that causes just perceptible erythema of
the skin. Current measures of skin type, commonly the
Fitzpatrick skin-type scale,23 provide a general guide to MED.
For fair-skinned Caucasian skin (Fitzpatrick type II), one MED
is approximately 2 to 3 SEDs.24 Other examples of these
relationships are provided in Zaratti et al. (2014).2
The maximum time that an individual can be outdoors
without risking erythema can be estimated from the UVI
approximation above and estimates of MED. For example, at a
UVI of 6, one hour of exposure delivers ∼6 SED; i.e. 1 SED each
10 min. For a person with skin type II (using a conservative
MED of 2 SED), the estimated maximum time outdoors
without erythema would be 20 minutes. Of note, the UVI refers
to the ambient UV radiation on a horizontal unshaded surface;
the calculated exposure thus applies only to a horizontal sun-
bather, or the vertex of someone standing upright, in an
unshaded environment.25 Under other conditions (e.g. in
environments where there may be shade from buildings, or on
exposed arms and legs while upright) the maximum time
required to achieve erythema will generally be longer than this
simple calculation, and will vary according to posture, body
site exposed and the local environment. This provides
additional conservatism in the estimates of time to erythema.
Is avoiding sunburn the appropriate
strategy?
Using the UVI to estimate the time to achieve minimal
erythema, as outlined above, should help ensure that sunburn
does not occur. However, DNA damage occurs even with sub-
erythemal doses of UV radiation26 and the damage may
persist, at least in an animal model.27 Recent research has
shown that human skin contains large numbers of evolving
clones of abnormal cells that contain a high proportion of
cancer-causing mutations.28 Most of these clones will never
develop into a skin cancer; animal studies show that normal
(non-mutated) cells in the epidermis actively eliminate
mutated cells, replacing the clones with normal skin architec-
ture.29 In addition, a recent laboratory study showed that
regular (3 times per week) low dose, non-sunburning (1.3 SED)
UV irradiation over 6 weeks was not associated with cumulative
DNA damage, as demonstrated by the lack of accumulation of
cyclobutane pyrimidine dimers in skin biopsies.30 The
accumulation of DNA damage depends on the extent of the
damage (a function of the dose of UV radiation and the indi-
vidual susceptibility) and capacity to eliminate mutated cells
or repair DNA (there is some evidence that the latter is
impaired by UVA irradiation, at least in laboratory studies).16
Better definition of the kinetics of damage and repair (both of
DNA and skin architecture) will inform future modifications of
sun protection messages; while the importance of dose to
avoid erythema is clear, messages may also need to incorporate
recommended non-exposure periods to avoid accumulation of
DNA damage.
Is UVI less than 3 “safe” without sun
protection?
For UVI values commonly encountered at Earth’s surface, the
development of erythema depends on the dose of UV radiation
rather than the rate at which it is delivered (this is termed
“reciprocity”).31 Thus, a dose of 2 SED can be received in
20 minutes at a UVI of 6, or in 60 minutes when the UVI is 2,
with a similar risk of erythema. This means that, for extended
periods outdoors with an average UVI near 3, some protection
should clearly be advised. It is inappropriate to base sun pro-
tection guidance on UVI reported as a simple binary (e.g. sun
protection is required only when the UVI is ≥3), because
whether or not protection is required depends on both the UVI
and the duration of exposure. Increasing sun protection is
required with increasing UVI and with increasing duration of
time outdoors.
There are several potential health consequences of pro-
longed exposure to UV radiation at UVI < 3 where, although
UVB doses are low, UVA doses may be considerable. First, an
erythemal dose can be achieved, as noted above (but with little
or no vitamin D production due to the low UVB dose). Second,
UVA irradiation has been shown to cause local immune sup-
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pression in human studies, with peak effectiveness at 370 nm
and with a bell-shaped dose response.18 We note that this is
contrary to older evidence from animal studies that exposure
to UVA counteracts the effects of UVB-induced immune sup-
pression.32 Whether this reflects the complexity of the effects
of UV radiation on immune suppression or a disparity in find-
ings between human and animal studies, is not clear. Third,
UVA irradiation causes release of nitric oxide from skin stores,
which has beneficial effects on the cardiovascular system.13
Finally, UVA may have at least as much influence as UVB on
photoageing.33,34
For any UVI, there is a wide range of possible values of UVA
(Fig. 1a). For any UVI value, the largest UVA values occur at
larger SZA. In contrast, the relationship between UVI and UVB
is approximately linear35 (Fig. 1b).
A UVI value of 3 can be achieved for a wide range of
conditions. Table 2 shows examples of ozone amounts (TOZ,
total column ozone amount) and cloud transmissions to
achieve UVI = 3, and the associated UVA irradiances for
selected SZAs.
Thus, for clear skies and the normal ranges of ozone
(outside the Antarctic ozone hole), UVA can vary by nearly a
factor of two for this given UVI value. A UVI value of 3 can also
be achieved under cloudy skies at smaller SZAs. Examples are
shown in the last two rows of Table 2. If such cloudy con-
ditions are included, UVA can vary by more than a factor of
four when the UVI is 3. The actual variability of UVA for a given
UVI at any given site depends on the range of ozone and SZA
observed at that site, and the cloudiness. For example, at
Lauder NZ (45°S) from where the data for Fig. 1 derive,
ozone ranges from 200 DU to 450 DU, and the minimum
SZA is 22°. At the current UVI threshold for sun protection
(UVI = 3, dotted line in Fig. 1a), values of UVA range from 10
to 45 W m−2.
Fig. 2 shows that even in the extreme example where the fre-
quency distributions for UVI > 10 and UVI < 3 are compared,
there is occasional overlap in the UVA irradiance.
Given that the UVA irradiance can be relatively high, even at
low UVI, we aimed to assess whether plausible levels of UVA
irradiance at UVI of 3 or below could have health conse-
quences. While we recognise that animal and human studies
provide different findings on the effects of UVA irradiation on
immune suppression, local immune suppression is one of the
few biological endpoints of UVA irradiation for which there are
quantitative data in humans. We use these data to illustrate
possible, rather than definitive, health consequences.
Damian and colleagues investigated the relative effects of
UVA and UVB irradiation on local immune suppression in 60
nickel-allergic volunteers.36 Our calculations (described in
full in ESI, including Tables S1 and S2†) show that with a UVA
irradiance of 45 W m−2 (the highest UVA irradiance observed
at UVI = 3 in Fig. 1a), maximum immune suppression occurs
Fig. 1 Variation of (a) UVA, (b) UVB and (c) vitamin D-effective irradiances, as a function of UVI measured at Lauder, NZ. Data are for all weather con-
ditions and approximately 135 000 spectral scans taken over the period 2001 to 2015 covering a range of SZA from 22° to 90°. Scans for SZA < 30°
(high sun) are highlighted in red, while scans for SZA > 60° (low sun) are highlighted in blue. Effects of temporal changes (e.g., due to changing
cloud and SZA) during the scans are small because each spectrum obtained is the mean of a forward scan and a reverse scan, with a total sampling
time of approximately 5 minutes.
Table 2 Total column ozone amount (TOZ) corresponding to UVI = 3
for a range of SZAs, along with corresponding UVA (280–315 nm) irradi-
ance. Calculations are for sea level at 1 AU Earth–Sun separation (i.e.
near the equinoxes) with the TUV radiative transfer model. The first 6
entries are for clear-sky conditions, and the last two are for moderate
and severe cloud attenuations, respectively
SZA (°) Cloud transmission TOZ for UVI = 3 (DU) UVA (W m−2)
70 1.0 105 16.1
65 1.0 160 21.2
60 1.0 220 26.5
55 1.0 300 31.6
50 1.0 380 36.5
45 1.0 470 41.6
30 0.5 395 27.0
0 0.15 200 9.9
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in 22 minutes (note the uncertainty in the estimate in
Fig. S2†).
Although this is an extreme of UVA irradiation that is poss-
ible when the UVI is 3, it illustrates that immunosuppression
can occur in a relatively short time at UVI just below 3, where
current messages advise that no sun protection is required.
Fig. 1a shows that when the UVI is 3, the UVA irradiance is
typically ∼30 W m−2, which can cause some degree of immune
suppression in less than 20 minutes. There is a comparable
effect for UVB irradiation, with maximum immune suppres-
sion in ∼27 minutes (ESI†).
Two caveats in extrapolating from this study are that immune
responses for the general population might be different to those
of the allergic people in this study, and that the duration of
the immune suppression, and thus its relevance for human
health effects, is not clear. Furthermore, the bell-shaped dose–
response relationship between UVA and immune suppression
may suggest that high doses of UVA could cancel out the sup-
pressive effects of smaller UVA doses.36
Should sun protection always be used
when the UVI is 3 or greater?
The best known beneficial effect of sun exposure is vitamin D
synthesis. Thus, the achievement and maintenance of vitamin
D sufficiency (25(OH)D > 50 nmol L−1) might be used to guide
a “healthy/necessary” amount of sun exposure. The currently
accepted action spectrum for vitamin D production is shifted
slightly toward shorter wavelengths compared to that for
erythema (Fig. S1†) and the UVI is a measure of erythemal
dose rate. Fig. 1c shows the association between UVI and
vitamin D-effective UV radiation. At higher UVI, 1 SED will
always include some amount of UVB irradiation (and thus
potential for vitamin D synthesis), while at lower UVI, 1 SED
may be achieved with mostly UVA irradiation, contributing to
erythema but only minimally to vitamin D production.
Sun exposure may also have non-vitamin D benefits37 that
cannot be achieved with vitamin D supplementation.
Observational studies show increased risks of a wide range of
diseases in association with 25(OH)D levels <50 nmol L−1.38
However, intervention studies have largely failed to show
benefits of vitamin D supplementation for non-skeletal out-
comes.39 The exceptions to this are a reduction in all-cause
mortality and cancer mortality in middle-aged and older people
with supplementation of 10–20 μg day−1,40 and a modest
reduction in common upper respiratory tract infections and
asthma exacerbations.40 Possible reasons for the discrepancy
between observational and intervention studies seen for most
health outcomes include reverse causality in observational
studies or issues related to trial design such as supplementing
people who are not vitamin D deficient, inadequate doses of
vitamin D, poor compliance, or supplementing people for too
short a time period.41 One other possible explanation for the
discrepancy is that it is not vitamin D per se that is beneficial,
but rather the sun exposure required to achieve 25(OH)D levels
>50 nmol L−1.37 In this case, a serum 25(OH)D level of >50
nmol L−1 could be seen as a marker of “sufficient” sun exposure.
Previous research has shown that 90% of Caucasians
(mainly skin type II) achieved vitamin D sufficiency with a
dose of UV radiation of 1.3 SEDs (of simulated midday
summer sun in Manchester, 53.5°North, UVI ≈ 6) three times
weekly for 6 weeks, with 35% of the body surface exposed
(short-sleeved shirt and shorts).42 The lowest MED for the
study population was 1.6 SED, showing that vitamin D
sufficiency occurred without erythema.
Vitamin D sufficiency should be achievable under current
messages to use sun protection when the UVI is 3 or greater,
provided sun protection is not complete (e.g., there is not com-
plete clothing coverage or sun avoidance such as staying
indoors). However, when the UVI is moderate (3 to 5), achiev-
ing vitamin D sufficiency may require exposure of unprotected
skin for a duration that is not practicable, given environmental
(e.g. cool weather that may accompany a moderate UVI) and
time constraints, particularly for those with darker skin. For
example, achieving vitamin D sufficiency under moderate UVI
conditions for darker-skinned individuals may require well
over an hour of exposure with 35% of the (horizontal43) body
surface exposed. Nevertheless, Farrar and colleagues have
shown that exposure of 35% of the body surface area to 1.95
SED (43 min at UVI = 3 or 26 min at UVI = 5) or higher can
take darker-skinned individuals out of the vitamin D
deficiency range (25(OH)D < 25 nmol L−1).44 If less skin area is
exposed, longer exposures will be required45 and the threshold
for sunburn to the exposed skin may be exceeded.
Discussion
The UV Index is a convenient tool on which to base messaging
around appropriate and safe sun exposure (a summary of con-
Fig. 2 Frequency distribution of UVA (y-axis, normalised to unity in
each case) for the case where UVI is less than 3 (red), and for the case
where UVI is greater than 10 (blue). The data used are the same as
shown in Fig. 1 (i.e., daytime scans only). In nearly 5–10% of cases, the
UVA for UVI < 3 is greater than that for UVI > 10.
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siderations is provided in Table S3†). It removes the need to
provide messages according to location, season, time of day
and atmospheric conditions. It is available in many countries
through daily media, online, or through mobile phone apps.
Nevertheless, at the moment, understanding of the UVI
remains poor in many countries.7,46,47
We have shown that with some knowledge of personal skin
type, a simple calculation can provide the maximum allowable
time outdoors before minimal erythema of the skin occurs.
There are safety factors built into this approximation, includ-
ing that exposure to full sunlight is unlikely for the full dur-
ation of the time outdoors, the calculation assumes exposure
to a horizontal unshaded surface, and the mathematical
approximation itself is conservative. We have also shown that
recommendations that sun protection is not required at UVI <
3 may be inappropriate, noting that the duration of time in the
sun needs to be considered along with the UVI to avoid
sunburn, and local immune suppression may occur even with
relatively short exposures. Furthermore, using the full range of
sun protection when the UVI is 3 or greater may lead to insuffi-
cient sun exposure for vitamin D production.
There have been calls to revise the UVI scale itself to better
reflect the extreme values that can occur outside Europe. For
example, the maximum category reported is currently 11+, but
in some locations the UVI can be more than twice as high as
this.2 The use of smartphone apps (e.g., GlobalUV, uv2Day, Uv-
indeks) that give information about how the UVI varies
throughout the day, along with appropriate messaging, have
the potential to facilitate education on the meaning and sig-
nificance of the UVI that had previously been lacking.
We believe revision of sun protection guidelines based on
the UVI is warranted, to avoid the health risks of exposure to
UV radiation and to gain the health benefits. Consideration
should be given to using the actual UVI rather than categories
such as UV Alert periods, and to reporting the UVI according
to the hour of the day (rather than just the maximum for the
day). A ‘one size fits all’ approach is simple, but may need to
be reconsidered to provide appropriate sun protection advice
to people with different skin types and/or cultural habits.
The UVI is a continuous scale of UV irradiance – the dose
of UV radiation also requires that the duration of exposure, i.e.
the time spent in the sun, is incorporated. With increasing
UVI, either the duration of exposure needs to decrease, or the
sun protection used needs to increase (effectively reducing the
dose of UV radiation reaching the skin and/or eyes), or both.
Sun protection messages sometimes consider a hierarchy of
protection – from staying indoors when the sun is most
intense, through using shade, sunglasses, a hat and covering
clothing, to sunscreen. Daily application of sunscreen has
been shown to reduce the risk of skin cancer.48 Thus while
sunscreen is clearly effective in reducing sunburning when
used in an ad hoc way, if skin cancer prevention is the desired
endpoint, the evidence-base indicates a message of daily appli-
cation. A major caveat is that this evidence derives from a very
sunny location, and a different message may be more appro-
priate for other regions of the world.
An additional consideration in public health messaging is
the concept of ‘acceptable risk’. Although there is evidence
that suberythemal sun exposure interspersed with non-
exposed periods does not lead to accumulation of damage30
there is unlikely to be any completely ‘safe’ level of exposure.
Thus in order to maintain vitamin D sufficiency, and achieve
other possible benefits of some sun exposure, a certain
amount of DNA damage – and thus risk of skin cancer – will
be incurred.
Conclusions
The UV Index is a valuable tool for health promotion messages
around safe sun exposure, but the exposure time is similarly
important and must be considered alongside UVI values.
Although current public understanding of the UVI is limited,
new technologies (e.g., the smartphone apps GlobalUV,
uv2Day, Uv-indeks) offer an opportunity to address the issues
raised here alongside increased promotion of, and education
about, the UVI.49 Effective communication of evidence-based
sun exposure/sun protection messages to the public remains a
major barrier to achieving significant institutional, collective
and individual change in sun exposure behaviours. Current
guidelines have been useful but were developed in the absence
of specific evidence and are somewhat simplistic. New evi-
dence is now available and should inform revision of guide-
lines for the future.
Glossary
Astronomical
unit:
1 Astronomical Unit (AU) is the mean separ-
ation between Earth and Sun. In Dec/Jan
(southern hemisphere summer) the radi-
ation incident outside Earth’s atmosphere
is about 3.5% more than at 1 AU, and in
Jun/Jul (northern hemisphere summer) it is
about 3.5% less.
Reciprocity
of response:
a given degree of the response, e.g.
erythema, depends only on the exposure
dose of radiation and not on the rate at
which the energy is administered.
Erythema: superficial reddening of the skin
MED: minimal erythema dose, the dose of UV
radiation that causes minimally perceptible
reddening of the skin within a few hours
following exposure
SED: standard erythemal dose, equal to 100
J m−2 of erythemally weighted UV radiation
UVI: UV Index, a unitless number that is defined
as 40 times the erythemally weighted UV
irradiance, when expressed in W m−2
UVA: UV radiation with wavelength of 315–400 nm
UVB: UV radiation with wavelength from
280–315 nm
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spectrum:
the effectiveness, as a function of specific
wavelengths of light, in producing a specific
biological endpoint
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